REGN

589.48

1.45% -8.68

Dopo l'orario di chiusura: 587.92 -1.56 -0.26%

Regeneron Pharmaceuticals Inc (REGN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché REGN Giù? Forum Previsione

Precedente Chiudi:

$598.16

Aprire:

$602.35

Volume 24 ore:

1.44M

Relative Volume:

1.27

Capitalizzazione di mercato:

$61.41B

Reddito:

$14.21B

Utile/perdita netta:

$4.46B

Rapporto P/E:

14.86

EPS:

39.68

Flusso di cassa netto:

$3.56B

1 W Prestazione:

+1.56%

1M Prestazione:

+5.09%

6M Prestazione:

-15.83%

1 anno Prestazione:

-50.37%

Intervallo 1D:

$585.50

$610.45

Intervallo di 1 settimana:

$570.39

$610.45

Portata 52W:

$476.49

$1,211.20

Regeneron Pharmaceuticals Inc Stock (REGN) Company Profile

Nome

Regeneron Pharmaceuticals Inc

Settore

Healthcare (1157)

Industria

Biotechnology (645)

Telefono

(914) 847-7000

Indirizzo

777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY

Dipendente

15,207

Cinguettio

@regeneron

Prossima data di guadagno

2025-08-01

Ultimi documenti SEC

REGN's Discussions on Twitter

Confronta REGN con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
REGN Regeneron Pharmaceuticals Inc	589.48	60.83B	14.21B	4.46B	3.56B	39.68
VRTX Vertex Pharmaceuticals Inc	395.12	99.96B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	454.38	59.89B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	660.00	40.47B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	313.67	37.96B	3.81B	-644.79M	-669.77M	-6.24

Regeneron Pharmaceuticals Inc Stock (REGN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-08-14	Iniziato	Rothschild & Co Redburn	Buy
2025-06-30	Downgrade	Argus	Buy → Hold
2025-05-30	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2025-05-30	Downgrade	Wells Fargo	Overweight → Equal Weight
2025-05-14	Aggiornamento	Citigroup	Neutral → Buy
2025-04-22	Ripresa	Cantor Fitzgerald	Overweight
2025-02-05	Aggiornamento	Leerink Partners	Market Perform → Outperform
2025-01-16	Downgrade	UBS	Buy → Neutral
2024-12-10	Ripresa	BofA Securities	Underperform
2024-11-15	Iniziato	Wolfe Research	Outperform
2024-11-14	Iniziato	Citigroup	Neutral
2024-09-24	Downgrade	Leerink Partners	Outperform → Market Perform
2024-03-12	Iniziato	Bernstein	Outperform
2024-01-12	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2023-11-09	Iniziato	Deutsche Bank	Hold
2023-11-03	Aggiornamento	Raymond James	Mkt Perform → Outperform
2023-08-21	Aggiornamento	Canaccord Genuity	Hold → Buy
2023-08-21	Reiterato	Oppenheimer	Perform
2023-06-28	Downgrade	Canaccord Genuity	Buy → Hold
2023-03-27	Aggiornamento	SVB Securities	Market Perform → Outperform
2023-03-24	Aggiornamento	Jefferies	Hold → Buy
2023-03-23	Aggiornamento	Raymond James	Underperform → Mkt Perform
2023-01-30	Aggiornamento	Cowen	Market Perform → Outperform
2023-01-20	Aggiornamento	JP Morgan	Neutral → Overweight
2022-10-26	Downgrade	Raymond James	Mkt Perform → Underperform
2022-10-17	Downgrade	Evercore ISI	Outperform → In-line
2022-09-09	Aggiornamento	Jefferies	Underperform → Hold
2022-09-09	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2022-07-25	Downgrade	SVB Leerink	Outperform → Mkt Perform
2022-07-13	Iniziato	Cantor Fitzgerald	Neutral
2022-06-06	Iniziato	Jefferies	Underperform
2022-05-23	Iniziato	SVB Leerink	Outperform
2022-01-05	Downgrade	BofA Securities	Neutral → Underperform
2022-01-03	Aggiornamento	Bernstein	Mkt Perform → Outperform
2021-12-15	Downgrade	Bernstein	Outperform → Mkt Perform
2021-12-09	Ripresa	Wells Fargo	Overweight
2021-12-07	Ripresa	Cowen	Market Perform
2021-12-06	Iniziato	Goldman	Buy
2021-11-19	Ripresa	BMO Capital Markets	Outperform
2021-11-05	Downgrade	The Benchmark Company	Buy → Hold
2021-06-29	Iniziato	H.C. Wainwright	Buy
2021-01-25	Aggiornamento	BMO Capital Markets	Market Perform → Outperform
2021-01-13	Aggiornamento	The Benchmark Company	Hold → Buy
2021-01-08	Aggiornamento	Citigroup	Neutral → Buy
2020-10-05	Aggiornamento	Cantor Fitzgerald	Neutral → Overweight
2020-08-20	Downgrade	The Benchmark Company	Buy → Hold
2020-07-09	Aggiornamento	SunTrust	Hold → Buy
2020-05-26	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2020-04-28	Downgrade	Citigroup	Buy → Neutral
2020-04-17	Aggiornamento	The Benchmark Company	Hold → Buy
2020-04-08	Iniziato	The Benchmark Company	Hold
2020-03-31	Iniziato	Wolfe Research	Peer Perform
2020-02-27	Iniziato	Barclays	Overweight
2020-02-26	Aggiornamento	Canaccord Genuity	Hold → Buy
2020-02-26	Downgrade	Robert W. Baird	Outperform → Neutral
2020-02-25	Aggiornamento	Jefferies	Hold → Buy
2020-02-11	Aggiornamento	Argus	Hold → Buy
2019-12-24	Iniziato	Raymond James	Mkt Perform
2019-12-16	Downgrade	Evercore ISI	Outperform → In-line
2019-12-13	Aggiornamento	Credit Suisse	Neutral → Outperform
2019-11-12	Iniziato	SunTrust	Hold
2019-11-07	Aggiornamento	Citigroup	Neutral → Buy
2019-10-17	Ripresa	BofA/Merrill	Neutral
2019-09-23	Aggiornamento	Guggenheim	Neutral → Buy

Mostra tutto

Regeneron Pharmaceuticals Inc Borsa (REGN) Ultime notizie

Aug 20, 2025

Regeneron Surges on FDA Delay as $0.77B Volume Ranks in Top 500 - AInvest

Aug 20, 2025

FDA Pushes Back Eylea HD Review; Regeneron Still Gains - Yahoo Finance

Aug 20, 2025

Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Aug 20, 2025

Scholar Rock jumps following Regeneron Eylea update - Seeking Alpha

Aug 20, 2025

Element Capital Management LLC Purchases New Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 20, 2025

Regeneron's Eylea injection review dates delayed by FDA (REGN) - Seeking Alpha

Aug 20, 2025

Aberdeen Group plc Acquires 56,746 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 20, 2025

Fox Run Management L.L.C. Buys Shares of 1,734 Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 20, 2025

Regeneron Pharmaceuticals Announces FDA Extension for EYLEA HD® Regulatory Submissions to Q4 2025 - Quiver Quantitative

Aug 20, 2025

Regeneron Says FDA Will Take More Time to Review Its Two Eylea HD Submissions - Stocktwits

Aug 20, 2025

FDA Extends Review Timeline: Regeneron's EYLEA HD Faces Q4 2025 Decision for Expanded Uses - Stock Titan

Aug 20, 2025

RWA Wealth Partners LLC Decreases Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat

Aug 20, 2025